Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AUROBINDO PHARMA LTD. - Completion Of US FDA Inspection At Unit IV Of APL Healthcare Ltd
Download announcement < Back
20 Sep 2023
The USFDA inspected Unit IV, a formulation manufacturing facility of APL Healthcare Limited, a wholly owned subsidiary of the Company from September 13 to September 19, 2023. At the end of the inspection a Form 483 was issued with one observation which is procedural in nature.
View all announcements for AUROBINDO PHARMA LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips